20-Revised JA 12042024_Redacted.pdf

This is a Justification and Approval (J&A) document for other than full and open competition under FAR Subpart 6.3 for a Cost-Plus-Fixed-Fee task order awarded to MITRE Corporation. The task order (HT001125F0059) is valued at $1,898,842.00 for a 12-month period from 11/20/2024 to 11/19/2025, issued under MITRE's IRS Federally Funded Research and Development Center (FFRDC) Contract TIRNO99D00005.

The requirement is for MITRE to support the Defense Health Agency (DHA) Pharmaceuticals, Devices, and Medical Support Systems (PDMSS) Program Manager by developing portfolio risk and benefit data and R-Form Strategy for budget exhibits. Key tasks include conducting research on risk/benefit analysis frameworks, analyzing historical data, reviewing past budget exhibits, and providing recommendations for creating budget exhibits. The J&A cites 10 U.S.C. 2304(c)(3) as the authority for other than full and open competition, noting MITRE's unique qualifications and previous experience with DHA acquisitions. Market research conducted from 5/28/2024 to 5/30/2024 reviewed responses from four firms (RJY Group LLC, Emerge Solutions Group LLC, Eagle Global Scientific LLC, and MITRE) with MITRE being determined as the only qualified source.